Tobias Financial Advisors, Inc. Trevena Inc Transaction History

Tobias Financial Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	BUY	$0.41 - $0.63 $16,400 - $25,200	40,000 New	40,000 $22,000
Q4 2021 Feb 09, 2022	SELL	$0.57 - $1.29 $18,639 - $42,183	-32,700 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$1.53 - $3.13 $15,300 - $31,300	10,000 Added 44.05%	32,700 $98,000
Q4 2019 Feb 04, 2020	BUY	$0.62 - $1.06 $14,074 - $24,062	22,700 New	22,700 $19,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $691M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Tobias Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tobias Financial Advisors, Inc. with notifications on news.